Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA.

Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M.

Nat Med. 2007 Dec;13(12):1510-4. Epub 2007 Nov 11.

PMID:
17994102
2.

Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?

Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, Long RD, Dorward DW, Gardner DJ, Lina G, Kreiswirth BN, DeLeo FR.

J Infect Dis. 2006 Dec 15;194(12):1761-70. Epub 2006 Nov 2.

PMID:
17109350
3.

Hyperexpression of α-hemolysin explains enhanced virulence of sequence type 93 community-associated methicillin-resistant Staphylococcus aureus.

Chua KY, Monk IR, Lin YH, Seemann T, Tuck KL, Porter JL, Stepnell J, Coombs GW, Davies JK, Stinear TP, Howden BP.

BMC Microbiol. 2014 Feb 10;14:31. doi: 10.1186/1471-2180-14-31.

5.

Community-acquired methicillin-resistant Staphylococcus aureus infections.

Maltezou HC, Giamarellou H.

Int J Antimicrob Agents. 2006 Feb;27(2):87-96. Epub 2006 Jan 19. Review.

PMID:
16423509
6.

Virulence determinants associated with the Asian community-associated methicillin-resistant Staphylococcus aureus lineage ST59.

Li M, Dai Y, Zhu Y, Fu CL, Tan VY, Wang Y, Wang X, Hong X, Liu Q, Li T, Qin J, Ma X, Fang J, Otto M.

Sci Rep. 2016 Jun 14;6:27899. doi: 10.1038/srep27899.

7.

Community-associated methicillin-resistant Staphylococcus aureus skin infections: advances toward identifying the key virulence factors.

Nygaard TK, DeLeo FR, Voyich JM.

Curr Opin Infect Dis. 2008 Apr;21(2):147-52. doi: 10.1097/QCO.0b013e3282f64819. Review.

PMID:
18317037
8.

Secrets of a superbug.

Lowy FD.

Nat Med. 2007 Dec;13(12):1418-20. No abstract available.

PMID:
18064034
9.

Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin.

Boyle-Vavra S, Daum RS.

Lab Invest. 2007 Jan;87(1):3-9. Epub 2006 Dec 4. Review.

10.

Community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus virulence toward Caenorhabditis elegans compared.

Day SR, Moore CM, Kundzins JR, Sifri CD.

Virulence. 2012 Nov 15;3(7):576-82. doi: 10.4161/viru.22120. Epub 2012 Oct 17.

11.

Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China.

Wu D, Wang Q, Yang Y, Geng W, Wang Q, Yu S, Yao K, Yuan L, Shen X.

Diagn Microbiol Infect Dis. 2010 May;67(1):1-8. doi: 10.1016/j.diagmicrobio.2009.12.006. Epub 2010 Mar 12.

PMID:
20227225
12.

New patterns of methicillin-resistant Staphylococcus aureus (MRSA) clones, community-associated MRSA genotypes behave like healthcare-associated MRSA genotypes within hospitals, Argentina.

Egea AL, Gagetti P, Lamberghini R, Faccone D, Lucero C, Vindel A, Tosoroni D, Garnero A, Saka HA, Galas M; S. aureus Study Group-Argentina, Bocco JL, Corso A, Sola C.

Int J Med Microbiol. 2014 Nov;304(8):1086-99. doi: 10.1016/j.ijmm.2014.08.002. Epub 2014 Aug 12.

PMID:
25240872
13.

Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence.

Graves SF, Kobayashi SD, DeLeo FR.

J Mol Med (Berl). 2010 Feb;88(2):109-14. doi: 10.1007/s00109-009-0573-x. Epub 2010 Jan 5. Review.

14.

Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan.

Chen CJ, Huang YC.

J Microbiol Immunol Infect. 2005 Dec;38(6):376-82. Review.

PMID:
16341337
15.

Community-acquired methicillin-resistant Staphylococcus aureus infections.

Palavecino E.

Clin Lab Med. 2004 Jun;24(2):403-18. Review.

PMID:
15177847
16.

Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillin-resistant USA400 Staphylococcus aureus isolates.

Shukla SK, Karow ME, Brady JM, Stemper ME, Kislow J, Moore N, Wroblewski K, Chyou PH, Warshauer DM, Reed KD, Lynfield R, Schwan WR.

J Clin Microbiol. 2010 Oct;48(10):3582-92. doi: 10.1128/JCM.00657-10. Epub 2010 Jul 28.

17.

Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.

Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC.

Clin Infect Dis. 2008 Mar 15;46(6):799-806. doi: 10.1086/527389.

PMID:
18266610
18.

Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.

Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC.

J Infect. 2007 May;54(5):427-34. Epub 2006 Oct 27.

PMID:
17070598
19.

Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives.

Kluytmans-Vandenbergh MF, Kluytmans JA.

Clin Microbiol Infect. 2006 Mar;12 Suppl 1:9-15. Review.

20.

Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains.

Memmi G, Filipe SR, Pinho MG, Fu Z, Cheung A.

Antimicrob Agents Chemother. 2008 Nov;52(11):3955-66. doi: 10.1128/AAC.00049-08. Epub 2008 Aug 25.

Supplemental Content

Support Center